Home/Filings/4/0001133416-24-000056
4//SEC Filing

FREEMAN KEVIN D 4

Accession 0001133416-24-000056

CIK 0001133416other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:12 PM ET

Size

6.8 KB

Accession

0001133416-24-000056

Insider Transaction Report

Form 4
Period: 2024-10-16
Transactions
  • Purchase

    Common Stock

    2024-10-16$2.70/sh+5,000$13,50080,000 total(indirect: By LLC)
  • Purchase

    Common Stock

    2024-10-16$2.70/sh+5,000$13,50033,469 total
Holdings
  • Common Stock

    (indirect: By IRA)
    18,063
Footnotes (1)
  • [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

GALECTIN THERAPEUTICS INC

CIK 0001133416

Entity typeother

Related Parties

1
  • filerCIK 0001522478

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:12 PM ET
Size
6.8 KB